Roberts, Glore & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $484K | Hold |
621
| – | – | 0.14% | 132 |
|
|
2025
Q1 | $513K | Buy |
621
+13
| +2% | +$10.7K | 0.16% | 123 |
|
|
2024
Q4 | $469K | Sell |
608
-5
| -0.8% | -$3.86K | 0.14% | 126 |
|
|
2024
Q3 | $543K | Sell |
613
-2
| -0.3% | -$1.77K | 0.16% | 121 |
|
|
2024
Q2 | $557K | Sell |
615
-10
| -2% | -$9.05K | 0.17% | 116 |
|
|
2024
Q1 | $486K | Sell |
625
-2
| -0.3% | -$1.56K | 0.15% | 120 |
|
|
2023
Q4 | $365K | Buy |
627
+30
| +5% | +$17.5K | 0.11% | 136 |
|
|
2023
Q3 | $321K | Buy |
597
+25
| +4% | +$13.4K | 0.11% | 148 |
|
|
2023
Q2 | $268K | Sell |
572
-20
| -3% | -$9.38K | 0.09% | 170 |
|
|
2023
Q1 | $203K | Buy |
+592
| New | +$203K | 0.07% | 194 |
|
|
2022
Q1 | – | Sell |
-735
| Closed | -$203K | – | 208 |
|
|
2021
Q4 | $203K | Buy |
+735
| New | +$203K | 0.05% | 202 |
|